Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD
Clinical trial NCT02318082 · COMPLETED
Trial details
- NCT number
- NCT02318082
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.